AAAAAA

   
Results: 1-16 |
Results: 16
GENERATION OF CEA PEPTIDE-SPECIFIC CYTOTOXIC T-CELLS IN-VIVO FROM HLA-A2.1K(B) TRANSGENIC MICE USING PEPTIDE-PULSED BONE-MARROW (BM)-DERIVED DENDRITIC CELLS (DC)
Authors: TSANG KY CORREALE P ZHU M TERASAWA H ARLEN P ZAREMBA S SCHLOM J
Citation: Ky. Tsang et al., GENERATION OF CEA PEPTIDE-SPECIFIC CYTOTOXIC T-CELLS IN-VIVO FROM HLA-A2.1K(B) TRANSGENIC MICE USING PEPTIDE-PULSED BONE-MARROW (BM)-DERIVED DENDRITIC CELLS (DC), The FASEB journal, 12(4), 1998, pp. 1613-1613
GENERATION OF HUMAN CYTOLYTIC T-LYMPHOCYTE LINES DIRECTED AGAINST PROSTATE-SPECIFIC ANTIGEN (PSA) EMPLOYING A PSA OLIGOEPITOPE PEPTIDE
Authors: CORREALE P WALMSLEY K ZAREMBA S ZHU MZ SCHLOM J TSANG KY
Citation: P. Correale et al., GENERATION OF HUMAN CYTOLYTIC T-LYMPHOCYTE LINES DIRECTED AGAINST PROSTATE-SPECIFIC ANTIGEN (PSA) EMPLOYING A PSA OLIGOEPITOPE PEPTIDE, The Journal of immunology (1950), 161(6), 1998, pp. 3186-3194
OLANZAPINE COMPARED WITH CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA
Authors: CONLEY RR TAMMINGA CA BARTKO JJ RICHARDSON C PESZKE M LINGLE J HEGERTY J LOVE R GOUNARIS C ZAREMBA S
Citation: Rr. Conley et al., OLANZAPINE COMPARED WITH CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA, The American journal of psychiatry, 155(7), 1998, pp. 914-920
IN-VITRO GENERATION OF HUMAN CYTOTOXIC T-LYMPHOCYTES SPECIFIC FOR PEPTIDES DERIVED FROM PROSTATE-SPECIFIC ANTIGEN
Authors: CORREALE P WALMSLEY K NIERODA C ZAREMBA S ZHU MZ SCHLOM J TSANG KY
Citation: P. Correale et al., IN-VITRO GENERATION OF HUMAN CYTOTOXIC T-LYMPHOCYTES SPECIFIC FOR PEPTIDES DERIVED FROM PROSTATE-SPECIFIC ANTIGEN, Journal of the National Cancer Institute, 89(4), 1997, pp. 293-300
PHENOTYPIC STABILITY OF A CYTOTOXIC T-CELL LINE DIRECTED AGAINST AN IMMUNODOMINANT EPITOPE OF HUMAN CARCINOEMBRYONIC ANTIGEN
Authors: TSANG KY ZHU MZ NIERODA CA CORREALE P ZAREMBA S HAMILTON JM COLE D LAM C SCHLOM J
Citation: Ky. Tsang et al., PHENOTYPIC STABILITY OF A CYTOTOXIC T-CELL LINE DIRECTED AGAINST AN IMMUNODOMINANT EPITOPE OF HUMAN CARCINOEMBRYONIC ANTIGEN, Clinical cancer research, 3(12), 1997, pp. 2439-2449
EVALUATING ABILITY TO CONSENT IN PSYCHOTIC INPATIENTS
Authors: CONLEY RR ZAREMBA S MCMULLEN R LOVE R
Citation: Rr. Conley et al., EVALUATING ABILITY TO CONSENT IN PSYCHOTIC INPATIENTS, Schizophrenia research, 24(1-2), 1997, pp. 206-206
RECOMBINANT VACCINIA VIRUS (RV) EXPRESSION OF A CTL EPITOPE FROM CARCINOEMBRYONIC ANTIGEN (CEA)
Authors: GUPTILL VA ZAREMBA S SCHLOM J KANTOR JA
Citation: Va. Guptill et al., RECOMBINANT VACCINIA VIRUS (RV) EXPRESSION OF A CTL EPITOPE FROM CARCINOEMBRYONIC ANTIGEN (CEA), Journal of allergy and clinical immunology, 99(1), 1997, pp. 186-186
IDENTIFICATION OF AN ENHANCER AGONIST CYTOTOXIC T-LYMPHOCYTE PEPTIDE FROM HUMAN CARCINOEMBRYONIC ANTIGEN
Authors: ZAREMBA S BARZAGA E ZHU MZ SOARES N TSANG KY SCHLOM J
Citation: S. Zaremba et al., IDENTIFICATION OF AN ENHANCER AGONIST CYTOTOXIC T-LYMPHOCYTE PEPTIDE FROM HUMAN CARCINOEMBRYONIC ANTIGEN, Cancer research, 57(20), 1997, pp. 4570-4577
THE PROTON THERAPY SYSTEM FOR THE NPTC - EQUIPMENT DESCRIPTION AND PROGRESS REPORT
Authors: JONGEN Y LAYCOCK S ABS M AMELIA JC BEECKMAN W KLEEVEN W LADEUZE M LANNOYE G LEYMAN D POREYE V VANDEPLASSCHE D ZAREMBA S HURN T NISSLEY L HUBBARD E HEIBERGER M TABOR M SILKE C TACHIKAWA T SANO M TAKAYAMA T OHTOMO K SATOH T
Citation: Y. Jongen et al., THE PROTON THERAPY SYSTEM FOR THE NPTC - EQUIPMENT DESCRIPTION AND PROGRESS REPORT, Nuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms, 113(1-4), 1996, pp. 522-525
IDENTIFICATION OF OVERLAPPING EPITOPES IN MUTANT RAS ONCOGENE PEPTIDES THAT ACTIVATE CD4(+) AND CD8(+)T CELL RESPONSES
Authors: ABRAMS SI STANZIALE SF LUNIN SD ZAREMBA S SCHLOM J
Citation: Si. Abrams et al., IDENTIFICATION OF OVERLAPPING EPITOPES IN MUTANT RAS ONCOGENE PEPTIDES THAT ACTIVATE CD4(+) AND CD8(+)T CELL RESPONSES, European Journal of Immunology, 26(2), 1996, pp. 435-443
GENERATION OF HUMAN CYTOTOXIC T-CELLS SPECIFIC FOR HUMAN CARCINOEMBRYONIC ANTIGEN EPITOPES FROM PATIENTS IMMUNIZED WITH RECOMBINANT VACCINIA-CEA VACCINE
Authors: TSANG KY ZAREMBA S NIERODA CA ZHU MZ HAMILTON JM SCHLOM J
Citation: Ky. Tsang et al., GENERATION OF HUMAN CYTOTOXIC T-CELLS SPECIFIC FOR HUMAN CARCINOEMBRYONIC ANTIGEN EPITOPES FROM PATIENTS IMMUNIZED WITH RECOMBINANT VACCINIA-CEA VACCINE, Journal of the National Cancer Institute, 87(13), 1995, pp. 982-990
RWJ-37796, A NOVEL COMPOUND IN THE TREATMENT OF SCHIZOPHRENIA
Authors: CONLEY R GOUNARIS C ZAREMBA S
Citation: R. Conley et al., RWJ-37796, A NOVEL COMPOUND IN THE TREATMENT OF SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 152-152
PATIENT EDUCATION OF PSYCHOTIC SUBJECTS TO OBTAIN INFORMED CONSENT
Authors: ZAREMBA S MCMULLAN R DORER G CONLEY R
Citation: S. Zaremba et al., PATIENT EDUCATION OF PSYCHOTIC SUBJECTS TO OBTAIN INFORMED CONSENT, Schizophrenia research, 15(1-2), 1995, pp. 223-223
PEPTIDE-SPECIFIC ACTIVATION OF CYTOLYTIC CD4(-LYMPHOCYTES AGAINST TUMOR-CELLS BEARING MUTATED EPITOPES OF K-RAS P21() T)
Authors: ABRAMS SI DOBRZANSKI MJ WELLS DT STANZIALE SE ZAREMBA S MASUELLE L KANTOR JA SCHLOM J
Citation: Si. Abrams et al., PEPTIDE-SPECIFIC ACTIVATION OF CYTOLYTIC CD4(-LYMPHOCYTES AGAINST TUMOR-CELLS BEARING MUTATED EPITOPES OF K-RAS P21() T), European Journal of Immunology, 25(9), 1995, pp. 2588-2597
CLOZAPINE RESPONSE VARIES IN DEFICIT VS NON-DEFICIT SCHIZOPHRENIC SUBJECTS
Authors: CONLEY R RICHARDSON C KENT D GOUNARIS C ZAREMBA S
Citation: R. Conley et al., CLOZAPINE RESPONSE VARIES IN DEFICIT VS NON-DEFICIT SCHIZOPHRENIC SUBJECTS, Biological psychiatry, 35(9), 1994, pp. 746-746
CONSTRUCTION AND PURIFICATION OF DOMAIN-DELETED IMMUNOGLOBULIN VARIANTS OF THE RECOMBINANT CHIMERIC B72.3 (Y1) MONOCLONAL-ANTIBODY
Authors: CALVO B KASHIMIRI SVS HUTZELL P HAND PH SLAVINCHIORINI DC SCHLOM J ZAREMBA S
Citation: B. Calvo et al., CONSTRUCTION AND PURIFICATION OF DOMAIN-DELETED IMMUNOGLOBULIN VARIANTS OF THE RECOMBINANT CHIMERIC B72.3 (Y1) MONOCLONAL-ANTIBODY, Cancer biotherapy, 8(1), 1993, pp. 95-109
Risultati: 1-16 |